Singular Genomics Systems, Inc. (OMIC)
| Market Cap | 989.62M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 31.63M |
| EPS (ttm) | -4.76 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 76,180 |
| Open | 13.66 |
| Previous Close | 13.68 |
| Day's Range | 13.28 - 13.77 |
| 52-Week Range | 10.80 - 33.37 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 27.67 (+103.5%) |
| Est. Earnings Date | Nov 3, 2021 |
About OMIC
Singular Genomics Systems is a life science technology company that is leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. We developed a unique and proprietary NGS technology, which we refer to as our Sequencing Engine. This Sequencing Engine is the foundational platform technology that forms the basis of our products in development and our core product tenets: accuracy, speed, flexibility and scale. We are currently developing two integrated solutions. The G4...
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for OMIC stock is "Buy." The 12-month stock price forecast is 27.67, which is an increase of 103.46% from the latest price.
News
Singular Genomics Systems, Inc. to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
LA JOLLA, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., a company focused on delivering genomic technologies for the advancement of science and medicine, today announced it ...
Singular Genomics Systems, Inc. Announces Second Quarter Financial Results and Operations Update
LA JOLLA, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., a company focused on delivering genomic technologies for the advancement of science and medicine, today reported its ...
Singular Genomics Systems, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Optio...
LA JOLLA, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (“Singular Genomics”), a company focused on delivering genomic technologies for the advancement of science and medicin...
Singular Genomics Systems, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock
LA JOLLA, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (“Singular Genomics”), a company focused on delivering genomic technologies for the advancement of science and medicine...
Sequencing Startup Singular Genomics Files for $100M IPO
The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis.
Singular Genomics Systems IPO Registration Document (S-1)
Singular Genomics Systems, Inc. has filed to go public with an IPO on the NASDAQ.